Metalloproteasen

Metalloproteases are a family of proteolytic enzymes that require a metal ion at their active site to hydrolyze peptide bonds. The most common metal is zinc, though some members use other metals. In zinc-dependent metalloproteases, the active-site zinc is coordinated by histidine residues and a bound water molecule that is activated by a catalytic residue, typically a glutamate, to attack the peptide bond. Many metalloproteases are synthesized as inactive precursors that require proteolytic removal of a pro-domain for activation.

Major families include matrix metalloproteinases (MMPs), ADAMs (a disintegrin and metalloproteinases), and ADAMTS (ADAMTS proteoglycanases); bacterial counterparts such as thermolysin-like proteases also belong to this group. MMPs are secreted or membrane-anchored enzymes that degrade extracellular matrix components such as collagens, gelatin, laminin, and proteoglycans. Membrane-type MMPs (MT-MMPs) act at the cell surface and can activate other MMPs. ADAMs mediate ectodomain shedding of membrane proteins and release of signaling molecules; ADAMTS enzymes target proteoglycans in the matrix.

Physiological roles include normal development, tissue remodeling, wound healing, angiogenesis, and immune responses. Pathologically, dysregulated metalloproteases contribute to cancer invasion and metastasis, fibrosis, osteoarthritis, and cardiovascular diseases by breaking down extracellular matrix and modulating signaling pathways. Regulation occurs through transcriptional control, activation of zymogens, and inhibition by tissue inhibitors of metalloproteinases (TIMPs). Therapeutic strategies have aimed to inhibit metalloproteases, but broad-spectrum inhibitors have encountered limited clinical success due to side effects and redundancy in protease networks.

Historically, MMPs such as MMP-2 and MMP-9 (gelatinases) and MMP-1 (collagenase) have been studied extensively. The field continues to refine understanding of their regulation and context-dependent roles, with ongoing research into selective inhibitors and substrates to minimize adverse effects while preserving physiologic remodeling.